AMENDED AND RESTATED LICENSE AGREEMENTLicense Agreement • August 6th, 2018 • Gemphire Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED LICENSE AGREEMENT (this “Agreement”) is made effective as of the 2nd day of August, 2018 (the “Effective Date”), by and between Gemphire Therapeutics Inc., a Delaware corporation with offices at 17199 N. Laurel Park Dr., Suite 401, Livonia, MI 48152 (“LICENSEE”), and Pfizer Inc., a corporation organized and existing under the laws of Delaware with offices at 235 East 42nd Street, New York, NY 10017 (“PFIZER”). LICENSEE and PFIZER may, from time-to-time, be individually referred to as a “Party” and collectively referred to as the “Parties.”
